Interleukin Genetics Announces Conference Call To Discuss Second Quarter 2009 Results
08/06/2009
WALTHAM, Mass., Aug. 6 -- Interleukin Genetics, Inc. (NYSE Amex: ILI) announced today that it will host a conference call and webcast on Thursday, August 13, 2009, at 4:30 p.m. EDT to review the Company's business developments and second quarter financial results.
To access the live call, dial 877-440-5796 (domestic) or 719-325-4847 (international). The live webcast and replay access of the teleconference will be available on the Company's website at http://www.ilgenetics.com.
About Interleukin Genetics
Interleukin Genetics, Inc. develops and markets genetic tests, including its new brand of Inherent Health(TM) genetic test products that empower consumers to maintain health and wellness, and assists pharmaceutical companies in the development and marketing of targeted therapeutics. The Company leverages its research, intellectual property, and biomarker development experience to facilitate the emerging personalized health market. Interleukin Genetics is headquartered in Waltham, MA. For more information please visit www.ilgenetics.com.